A new study, led by researchers in the lab of Blossom Damania, PhD, has identified a new therapeutic target for difficult-to-treat cases of non-Hodgkin lymphoma.
“Our research indicates that targeting a single enzyme may offer a more effective approach for the treatment of EBV-positive NHL," said Maria White, PhD, a postdoctoral researcher in the Damania lab and lead author on the paper.
https://t.co/gf28EOAgll
📢Excited to share the first publication of the #SpecialIssue “Oncogenesis of Lymphoma”:
Title: Molecular Mechanisms of Kaposi Sarcoma-Associated Herpesvirus (HHV8)-Related Lymphomagenesis
by Caroline J. Yu @carolinejyu_ and Blossom Damania @DamaniaLab
🔗https://t.co/aUWfeoV60S
A model of a membrane called the blood–brain barrier could transform how scientists study drug delivery to the brain, as well as diseases of the brain’s vascular network https://t.co/Bpd5zp5FJp
This weekend the CHS Habitat club participated in Rake-a-Thon. We raked multiple houses to fundraise for @orangehabitat@Habitat_org
Thanks to all our @CHSJaguars who came out to help!
Day 2 of #ICMH2022 begins with #KSHV session - starts with Dr. Damania @DamaniaLab exploring how EBV and KSHV modulate host immunity - studying the interaction of these viruses and cGAS-STING pathway. Novel work presented and seminal 2015 paper here: https://t.co/Ev4PlCjLY0
New on the bivalent BA.5 vaccine booster immune response in people
No better neutralizing antibody response to BA.5 than the original vaccine (WT)
https://t.co/QT5emKLFXz
Wonderful tribute to Dr. Enrique Mesri @theNCI 18th International Conference on Malignancies in HIV/AIDS. Thanks to Ethel and Omar for this poignant tribute and thanks to Geraldina Dominguez and Bob Yarchoan for organizing.
https://t.co/zM71DW1hpA
@ecesarman@betaherpesvirus
“Now that we know that Epstein-Barr is very tightly linked to MS, we could save a lot of lives if we develop the vaccine now,” @DamaniaLab said, “rather than wait 10 years” until every question is answered. @cnn @KHNews https://t.co/QUqop6Zlg9
Herpesviruses, including Epstein-Barr, have “evolved with us for millions of years,” said @DamaniaLab, a @UNC virologist. “They know all your body’s secrets.”
📝: @LizSzabo https://t.co/KripYCIoNL
“Now that we know that Epstein-Barr is very tightly linked to MS, we could save a lot of lives if we develop the vaccine now,” said @DamaniaLab, “rather than wait 10 years” until every question is answered. https://t.co/SzPG06xLuI via @khnews
The immune evasion is more extensive for BA.4/5 than BA.2.12.1 variant, raising the possibility that the former can out-compete the latter. Only one clinically available monoclonal antibody (bebtelovimab) has full potency against these Omicron subvariants
https://t.co/IKqSKtzdR6
Unlike coronavirus, monkeypox infection, likely, induces sterilizing immunity for decades. Hence, even worldwide, this outbreak will, in all probability, be short-lived. Read @newsobserver op-ed from Dr. Dirk Dittmer and Dr. Blossom Damania.
https://t.co/0VHFzUNb37
Dr. Blossom Damania, @UNC_Health_Care virologist, talks with @WRALTV about the first reported case of #monkeypox in the U.S. and why we don't need to be alarmed.
https://t.co/n6BOJvZz6W
Vaccination against smallpox was halted in 1980- it was a very effective vaccine against smallpox and also offered 85% protection against monkeypox. Monkeypox virus infection was predicted to increase as smallpox vaccine protection drops in the human population globally.
Next on @GMA…we have the latest on the FDA’s decision to authorize that booster dose of the #Pfizer vaccine for kids 5-11-years old and @DrJAshton joins LIVE to share what parents should know before taking their kids to get a third shot.